AEENA Dx Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Employees
-
8
- Latest Deal Type
-
M&A
AEENA Dx General Information
Description
Developer of biofluid-based molecular diagnostic tests designed to make breast cancer detection accurate, accessible, and affordable for women anywhere. The company's tests offer breast cancer screening and diagnosis while improving the sensitivity and specificity of current mammography programs, enabling patients to detect breast cancer easily and take measures to reduce such cancer.
Contact Information
Website
www.aeenadx.comCorporate Office
- 319 North Bernardo Avenue
- Mountain View, CA 94043
- United States
Corporate Office
- 319 North Bernardo Avenue
- Mountain View, CA 94043
- United States
AEENA Dx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 01-Jan-2023 | Completed | Clinical Trials - General | |||
| 7. Grant | 03-Jun-2021 | Completed | Clinical Trials - General | |||
| 6. Later Stage VC (Series A1) | 01-May-2020 | Completed | Clinical Trials - General | |||
| 5. Later Stage VC (Series A) | 01-Jul-2019 | Completed | Clinical Trials - General | |||
| 4. Grant | 16-Apr-2019 | Completed | Startup | |||
| 3. Accelerator/Incubator | 29-Jul-2013 | Completed | Startup | |||
| 2. Angel (individual) | 27-Dec-2011 | $192K | $192K | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
AEENA Dx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
AEENA Dx Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
AEENA Dx Patents
AEENA Dx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3544605-A1 | Methods for cancer detection | Inactive | 22-Nov-2016 | ||
| US-20200081008-A1 | Methods for cancer detection | Inactive | 22-Nov-2016 | ||
| CA-3044257-A1 | Methods for cancer detection | Pending | 22-Nov-2016 | ||
| JP-2022163076-A | Methods for cancer detection | Pending | 22-Nov-2016 | ||
| EP-3544605-A4 | Methods for cancer detection | Inactive | 22-Nov-2016 | G01N33/57415 |
AEENA Dx Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
AEENA Dx Former Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aletta Angels | Angel Group | Minority | ||
| Band of Angels | Angel Group | Minority | ||
| DigitalDx Ventures | Venture Capital | Minority | ||
| For Good Ventures | Venture Capital | Minority | ||
| Angel (individual) | Minority |
AEENA Dx FAQs
-
When was AEENA Dx founded?
AEENA Dx was founded in 2010.
-
Where is AEENA Dx headquartered?
AEENA Dx is headquartered in Mountain View, CA.
-
What is the size of AEENA Dx?
AEENA Dx has 8 total employees.
-
What industry is AEENA Dx in?
AEENA Dx’s primary industry is Biotechnology.
-
Is AEENA Dx a private or public company?
AEENA Dx is a Private company.
-
What is AEENA Dx’s current revenue?
The current revenue for AEENA Dx is .
-
How much funding has AEENA Dx raised over time?
AEENA Dx has raised $7.81M.
-
Who are AEENA Dx’s investors?
Aletta Angels, Band of Angels, DigitalDx Ventures, For Good Ventures, and are 5 of 11 investors who have invested in AEENA Dx.
-
When was AEENA Dx acquired?
AEENA Dx was acquired on 01-Jan-2023.
-
Who acquired AEENA Dx?
AEENA Dx was acquired by NOWDiagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
